Following the acquisition of Parabolic Drugs by our Company in 2021, we entered the business of the manufacture and sale of key starting materials, intermediates and APIs, and acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an R&D centre in Barwala, Haryana. Details of our API units are set out below:
Dera Bassi, Punjab: This unit is dedicated to the production of beta lactams and is equipped with six production blocks. With an annual capacity of 557.00 MT. This unit enables us to carry out complex multistep synthesis processes, meeting the high demand for beta lactam APIs.
Lalru, Punjab: This unit is designed for the synthesis of a wide range of APIs spanning various therapy areas. This unit comprises three production blocks and has an annual production capacity of 180.00 MT. At this unit, we produce APIs across a broad spectrum of therapeutic categories.
Barwala, Haryana: This unit is a specialized small-volume, high-potency API manufacturing unit with an annual production capacity of 0.38 MT. This unit features a kilo lab scale pilot plant for experimental and development purposes and is dedicated to handling high-potency APIs with a high degree of expertise.
State-of-the-art manufacturing facilities with global reach, capable of producing APIs at scale